Palliative radiation therapy for advanced gastrointestinal cancer

Digestion

Volumn 77, Issue SUPPL. 1, 2008, Pages 29-35

  Murakami, Naoya ^a   Nakagawa, Keiichi ^a   Yamashita, Hideomi ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Brachytherapy; Colorectal cancer; Esophageal cancer; Gastric cancer; Gastrointestinal cancer; Palliative radiation therapy

Indexed keywords

ADVANCED CANCER; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; ESOPHAGUS CANCER; HUMAN; PALLIATIVE THERAPY; PRIORITY JOURNAL; RECURRENT CANCER; STOMACH CANCER; CANCER STAGING; GASTROINTESTINAL TUMOR; HOSPITALIZATION; METHODOLOGY; PATHOLOGY; REVIEW; TREATMENT OUTCOME;

GASTROINTESTINAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PALLIATIVE CARE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 40949136221     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111485     Document Type: Conference Paper

References (33)

1. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000: the global picture. Eur J Cancer 2001;37(suppl 8):S4-S66.
2. Sagar PM, Gauperaa T, Sue-Ling H, et al: An audit of the treatment of cancer of the oesophagus. Gut 1994;35:941-945.
3. De Palma GD, Galloro G, Sivero L, et al: Self-expanding metal stents for palliation of inoperable carcinoma of the esophagus and gastroesophageal junction. Am J Gastroenterol 1995;90:2140-2142.
4. Siersema PD, Hop WC, van Blankenstein M, et al: A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001;54:145-153.
5. Kozarek RA, Raltz S, Brugge WR, et al: Prospective multicenter trial of esophageal Zstent placement for malignant dysphagia and tracheoesophageal fistula. Gastrointest Endosc 1996;44:562-567.
6. Raijman I, Siddeque I, Ajani J, et al: Palliation of management dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc 1998;48:172-179.
7. Bartelsman JF, Bruno MJ, Jensema AJ, et al: Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients. Gastrointest Endosc 2000;51:134-138.
8. Spencer GM, Thorpe SM, Blackman GM, et al: Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomized study. Gut 2002;50:224-227.
9. Dallal HJ, Smith GD, Grieve DC, et al: A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001;54:549-557.
10. Taal BG, Aleman BM, Koning CC, et al: High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer 1996;74:1452-1457.
11. Schraube P, Fritz P, Wannenmacher MF: Combined endoluminal and external irradiation of inoperable oesophageal carcinoma. Radiother Oncol 1997;44:45-51.
12. Homs MY, Eijkenboom WM, Coen VL, et al: High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol 2003;66:327-332.
13. Brewster AE, Davidson SE, Makin WP, et al: Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 1995;7:102-105.
14. Rowland CG, Pagliero KM: Intracavitary irradiation in palliation of carcinoma of oesophagus and cardia. Lancet 1985;2:981-983.
15. Kulhavy M, Sur RK, Levin CV, et al: Optimization of single-fraction high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer: a preliminary report. Endocurie Hypertherm Oncol 1995;11:235-239.
16. Sur RK, Donde B, Levin VC, et al: Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys 1998;40:447-553.
17. Sur RK, Levin CV, Donde B, et al: Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma - an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys 2002;53:127-133.
18. Sharma V, Mahantshetty U, Dinshaw KA, et al: Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2002;52:310-315.
19. Jager J, Langendijk H, Pannebakker M, et al: A single session of intraluminal brachytherapy in palliation of esophageal cancer. Radiother Oncol 1995;37:237-240.
20. Homs MY, Steyerberg EW, Eijkenboom WM, et al: Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomized trial. Lancet 2004;364:1497-1504.
21. Gaspar LE, Nag S, Herskovic A, et al: American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. Int J Radiat Oncol Biol Phys 1997;38:127-132.
22. Ries LAG, Eisner M, Kosary CL: SEER Cancer Statistics Review, 1975-2002. Bethesda, National Cancer Institute, 2004.
23. Perez C, Brady LW, Halperin EC: Principles and Practice of Radiation Oncology, ed 4. Philadelphia, Lippincott Williams & Wilkins, 2004.
24. Tey J, Back MF, Shakespeare TP, Mukherjee RK, Lu JJ, Lee KM, Wong LC, Leong CN, Zhu M: The role of palliative radiation therapy in symptomatic locally advanced gastric cancer. Int J Radiat Oncol Biol Phys 2007;67:385-388.
25. Salazar OM, Rubin P, Hendrickson FR, et al: Single-dose half-body irradiation for palliation of multiple bone metastasis from solid tumor: final RTOG report. Cancer 1986;58:29-36.
26. Hazard L, O'Connor J, Scaife C: Role of radiation therapy in gastric adenocarcinoma. World J Gastroenterol 2006;12:1511-1520.
27. Hazard L, O'Connor J, Scaife C: Role of radiation therapy in gastric adenocarcinoma. World J Gastroenterol 2006;12:1511-1520.
28. Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY Jr, Holbrook MA: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865-867.
29. Schein P, Novak H;for GITSG: Combined modality therapy (XRT-chemo) versus chemotherapy alone for locally unresectable gastric cancer. Cancer Chemother Pharmacol 1982;49:1771.
30. Bleiberg H, Goffin JC, Dalesio O, Buyse M, Pector JC, Gignoux M, Roussel A, Samana G, Michel J, Gerard A, et al: Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the gastrointestinal tract cancer cooperative group of the EORTC. Eur J Surg Oncol 1989;15:535-543.
31. Gunderson LL, Hoskins RB, Cohen AC, Kaufman S, Wood WC, Carey RW: Combined modality treatment of gastric cancer. Int J Radiat Oncol Biol Phys 1983;9:965-975.
32. Hoskin PJ, de Canha SM, Bownes P, Bryant L, Glynne Jones R: High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Radiother Oncol 2004;73:195-198.
33. Kolotas C, Röddiger S, Strassmann G, Martin T, Tselis N, Aebersold DM, Baltas D, Zamboglou N: Palliative interstitial HDR brachytherapy for recurrent rectal cancer. Strahlenther Onkol 2003;179:458-463.